Introduction - SGLT2 inhibition, diabetes and CVD: where does this fit in CV risk management?
28 August 2016 (12:45 - 12:50)
Organised by:
About the speaker
St. Michael's Hospital, Toronto (Canada)
4 More presentations in this session
Professor S. Inzucchi (New Haven, US)
Doctor D. Fitchett (Toronto, CA)
Professor J. McMurray (Glasgow, GB)
Access the full session
The Event
ESC Congress 2016
28 August 2016
12:45 CET
